PPT-Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Author : ximena | Published Date : 2024-01-29

Kirschner DE Webb G Resistance Remission and Qualitative Differences in HIV Chemotherapy Emerg Infect Dis 199733273283 httpsdoiorg103201eid0303970303

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 5 Figure 5. 5a simulates..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient: Transcript

Kirschner DE Webb G Resistance Remission and Qualitative Differences in HIV Chemotherapy Emerg Infect Dis 199733273283 httpsdoiorg103201eid0303970303. Lemaire B, Normand A, Forel J, Cassir N, Piarroux R, Ranque S. Hospitalized Patient as Source of Aspergillus fumigatus, 2015. Emerg Infect Dis. 2018;24(8):1524-1527. https://doi.org/10.3201/eid2408.171865. Thirty six years of periodontal care: a case report BDS PhD.Department of Oral Medicine and Periodontology, School of Oral Health Sciences, University of the Witwatersrand, Johannesburg.BDS Dip Orth.D Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E. Antibacterial Cleaning Products and Drug Resistance. Emerg Infect Dis. 2005;11(10):1565-1570. https://doi.org/10.3201/eid1110.041276. Faber WR, Hoekzema R, Bart A, Zeegelaar JE, de Vries H. Cutaneous Leishmaniasis Acquired in Jura, France. Emerg Infect Dis. 2012;18(1):183-184. https://doi.org/10.3201/eid1801.110408. Kee AC, Yang S, Tambyah P. Atypical Chikungunya Virus Infections in Immunocompromised Patients. Emerg Infect Dis. 2010;16(6):1038-1040. https://doi.org/10.3201/eid1606.091115. Larsson P, Svensson K, Karlsson L, Guala D, Granberg M, Forsman M, et al. Canonical Insertion-Deletion Markers for Rapid DNA Typing of Francisella tularensis. Emerg Infect Dis. 2007;13(11):1725-1732. https://doi.org/10.3201/eid1311.070603. Sola C, Devallois A, Horgen L, Maïsetti J, Filliol I, Legrand E, et al. Tuberculosis in the Caribbean: Using Spacer Oligonucleotide Typing to Understand Strain Origin and Transmission. Emerg Infect Dis. 1999;5(3):404-411. https://doi.org/10.3201/eid0503.990311. Chung M, Lee S, Kim M, Lee J, Kim E, Lee J, et al. Japanese Spotted Fever, South Korea. Emerg Infect Dis. 2006;12(7):1122-1124. https://doi.org/10.3201/eid1207.051372. Han XY, Ho LX, Safdar A. Francisella tularensis Peritonitis in Stomach Cancer Patient. Emerg Infect Dis. 2004;10(12):2238-2240. https://doi.org/10.3201/eid1012.040497. Figure 2 details perceived communication barriers by PLHIV of HCPs by viral load status. Acknowledgments: . Authors would like to thank all the PLHIV that participated in this study. Data analyses and medical writing support were provided by . Metlay JP, Powers JH, Dudley MN, Christiansen K, Finch RG. Antimicrobial Drug Resistance, Regulation, and Research. Emerg Infect Dis. 2006;12(2):183-190. https://doi.org/10.3201/eid1202.050078. Marrie TJ, Campbell N, McNeil SA, Webster D, Hatchette TF. Q Fever Update, Maritime Canada. Emerg Infect Dis. 2008;14(1):67-69. https://doi.org/10.3201/eid1401.071256. Cassar O, Blondot M, Mohanna S, Jouvion G, Bravo F, Maco V, et al. Human Herpesvirus 8 Genotype E in Patients with Kaposi Sarcoma, Peru. Emerg Infect Dis. 2010;16(9):1459-1462. https://doi.org/10.3201/eid1609.100381. Klapsing P, MacLean JD, Glaze S, McClean KL, Drebot MA, Lanciotti RS, et al. Ross River Virus Disease Reemergence, Fiji, 2003–2004. Emerg Infect Dis. 2005;11(4):613-615. https://doi.org/10.3201/eid1104.041070.

Download Document

Here is the link to download the presentation.
"Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

ABSTRntroduction In 1978 a 15 year old male was referred to a periodo

Figure A1 Figure A1. Proportion of study participants with gram-negative bacteria

PPT-Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Presentation Embed Code

Download Presentation

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient: Transcript

ABSTRntroduction In 1978 a 15 year old male was referred to a periodo

Figure A1 Figure A1. Proportion of study participants with gram-negative bacteria

Figure Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis

Figure Figure. Magnetic resonance imaging of the brain of patient B, showing

Figure 4 Figure 4. Cladograms depicting relationships among Francisella tularensis

Figure 1 Figure 1. Distribution of tuberculosis cases reported to health authorities

Figure 1 Figure 1. Skin findings of the patient. A small eschar (arrow) on the

Figure Figure. Effect of tularemia and anticancer chemotherapy on the lymphocyte

Most of the study population reported being virally suppressed (74%); younger (<50

Figure 3 Figure 3. Relationship between MIC and attainment of the pharmacokinetic/pharmaco

Figure Figure. Chest radiograph of patient 11 at time of admission to hospital,

Figure 1 Figure 1. Histologic patterns of cutaneous Kaposi sarcoma (KS) associated

Figure Figure. Patient 1: ankle swelling, pain, tenderness, erythema, and warmth

PPT-Figure 5 Figure 5.&nbsp;5a simulates combined drug treatment data reported for a patient

Presentation Embed Code

Download Presentation

Figure 5 Figure 5.&nbsp;5a simulates combined drug treatment data reported for a patient: Transcript

ABSTRntroduction In 1978 a 15 year old male was referred to a periodo

Figure A1 Figure A1.&nbsp;Proportion of study participants with gram-negative bacteria

Figure Figure.&nbsp;A) Crustosus plaque on the nose of the patient. B) The epidermis

Figure Figure.&nbsp;Magnetic resonance imaging of the brain of patient B, showing

Figure 4 Figure 4.&nbsp;Cladograms depicting relationships among Francisella tularensis

Figure 1 Figure 1.&nbsp;Distribution of tuberculosis cases reported to health authorities

Figure 1 Figure 1.&nbsp;Skin findings of the patient. A small eschar (arrow) on the

Figure Figure.&nbsp;Effect of tularemia and anticancer chemotherapy on the lymphocyte

Most of the study population reported being virally suppressed (74%); younger (<50

Figure 3 Figure 3.&nbsp;Relationship between MIC and attainment of the pharmacokinetic/pharmaco

Figure Figure.&nbsp;Chest radiograph of patient 11 at time of admission to hospital,

Figure 1 Figure 1.&nbsp;Histologic patterns of cutaneous Kaposi sarcoma (KS) associated

Figure Figure.&nbsp;Patient 1: ankle swelling, pain, tenderness, erythema, and warmth

PPT-Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient: Transcript

Figure A1 Figure A1. Proportion of study participants with gram-negative bacteria

Figure Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis

Figure Figure. Magnetic resonance imaging of the brain of patient B, showing

Figure 4 Figure 4. Cladograms depicting relationships among Francisella tularensis

Figure 1 Figure 1. Distribution of tuberculosis cases reported to health authorities

Figure 1 Figure 1. Skin findings of the patient. A small eschar (arrow) on the

Figure Figure. Effect of tularemia and anticancer chemotherapy on the lymphocyte

Figure 3 Figure 3. Relationship between MIC and attainment of the pharmacokinetic/pharmaco

Figure Figure. Chest radiograph of patient 11 at time of admission to hospital,

Figure 1 Figure 1. Histologic patterns of cutaneous Kaposi sarcoma (KS) associated

Figure Figure. Patient 1: ankle swelling, pain, tenderness, erythema, and warmth